463 related articles for article (PubMed ID: 28132604)
21. Chemotherapy-Induced Peripheral Neuropathy: Causative Agents, Preventative Strategies, and Treatment Approaches.
Kachrani R; Santana A; Rogala B; Pawasauskas J
J Pain Palliat Care Pharmacother; 2020 Sep; 34(3):141-152. PubMed ID: 32118502
[TBL] [Abstract][Full Text] [Related]
22. Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review.
Schloss J; Colosimo M; Vitetta L
Crit Rev Food Sci Nutr; 2017 Apr; 57(6):1107-1118. PubMed ID: 25849070
[TBL] [Abstract][Full Text] [Related]
23. Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey.
McCrary JM; Goldstein D; Boyle F; Cox K; Grimison P; Kiernan MC; Krishnan AV; Lewis CR; Webber K; Baron-Hay S; Horvath L; Park SB;
Support Care Cancer; 2017 Nov; 25(11):3485-3493. PubMed ID: 28589310
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives.
Ewertz M; Qvortrup C; Eckhoff L
Acta Oncol; 2015 May; 54(5):587-91. PubMed ID: 25751757
[TBL] [Abstract][Full Text] [Related]
25. Scrambler therapy for chemotherapy neuropathy: a randomized phase II pilot trial.
Loprinzi C; Le-Rademacher JG; Majithia N; McMurray RP; O'Neill CR; Bendel MA; Beutler A; Lachance DH; Cheville A; Strick DM; Black DF; Tilburt JC; Smith TJ
Support Care Cancer; 2020 Mar; 28(3):1183-1197. PubMed ID: 31209630
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy-Induced Peripheral Neuropathy Assessment Tools: A Systematic Review.
Haryani H; Fetzer SJ; Wu CL; Hsu YY
Oncol Nurs Forum; 2017 May; 44(3):E111-E123. PubMed ID: 28635977
[TBL] [Abstract][Full Text] [Related]
27. Reflexology in the management of chemotherapy induced peripheral neuropathy: A pilot randomized controlled trial.
Kurt S; Can G
Eur J Oncol Nurs; 2018 Feb; 32():12-19. PubMed ID: 29353627
[TBL] [Abstract][Full Text] [Related]
28. The Efficacy of Acupuncture in the Treatment of Chemotherapy-Induced Peripheral Neuropathy: A Network Meta-Analysis.
Zhang T; Zhang Q; Zhu P; Sun W; Ding Z; Hu L
Altern Ther Health Med; 2023 Nov; 29(8):898-906. PubMed ID: 37708563
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy-induced peripheral neuropathy: a review of recent findings.
Kim PY; Johnson CE
Curr Opin Anaesthesiol; 2017 Oct; 30(5):570-576. PubMed ID: 28708674
[TBL] [Abstract][Full Text] [Related]
30. A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors.
Gewandter JS; Mohile SG; Heckler CE; Ryan JL; Kirshner JJ; Flynn PJ; Hopkins JO; Morrow GR
Support Care Cancer; 2014 Jul; 22(7):1807-14. PubMed ID: 24531792
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy-induced peripheral neuropathy in the adult.
Saad M; Tafani C; Psimaras D; Ricard D
Curr Opin Oncol; 2014 Nov; 26(6):634-41. PubMed ID: 25229554
[TBL] [Abstract][Full Text] [Related]
32. Management options for established chemotherapy-induced peripheral neuropathy.
Pachman DR; Watson JC; Lustberg MB; Wagner-Johnston ND; Chan A; Broadfield L; Cheung YT; Steer C; Storey DJ; Chandwani KD; Paice J; Jean-Pierre P; Oh J; Kamath J; Fallon M; Strik H; Koeppen S; Loprinzi CL
Support Care Cancer; 2014 Aug; 22(8):2281-95. PubMed ID: 24879391
[TBL] [Abstract][Full Text] [Related]
33. Acupuncture in adults with Chemotherapy-Induced Peripheral Neuropathy: a systematic review.
Baviera AF; Olson K; Paula JM; Toneti BF; Sawada NO
Rev Lat Am Enfermagem; 2019 Mar; 27():e3126. PubMed ID: 30916227
[TBL] [Abstract][Full Text] [Related]
34. [Chemotherapy-induced peripheral neuropathy].
Noguchi E; Maeda Y
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1773-6. PubMed ID: 22083183
[TBL] [Abstract][Full Text] [Related]
35. A systematic review of behavioural and exercise interventions for the prevention and management of chemotherapy-induced peripheral neuropathy symptoms.
Tanay MAL; Armes J; Moss-Morris R; Rafferty AM; Robert G
J Cancer Surviv; 2023 Feb; 17(1):254-277. PubMed ID: 33710510
[TBL] [Abstract][Full Text] [Related]
36. Acupuncture for chemotherapy-induced peripheral neuropathy (CIPN): a pilot study using neurography.
Schroeder S; Meyer-Hamme G; Epplée S
Acupunct Med; 2012 Mar; 30(1):4-7. PubMed ID: 22146780
[TBL] [Abstract][Full Text] [Related]
37. Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.
Hoshino N; Ganeko R; Hida K; Sakai Y
Int J Clin Oncol; 2018 Jun; 23(3):434-442. PubMed ID: 29270698
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy.
Hausheer FH; Schilsky RL; Bain S; Berghorn EJ; Lieberman F
Semin Oncol; 2006 Feb; 33(1):15-49. PubMed ID: 16473643
[TBL] [Abstract][Full Text] [Related]
39. Effects of the publication of Clinical Guidelines for the Management of Chemotherapy-Induced Peripheral Neuropathy on the Administration Preferences of Oncology Specialists: Japanese Association of Supportive Care in Cancer.
Hirayama Y; Yoshida Y; Mori M; Tamura K
Jpn J Clin Oncol; 2020 Aug; 50(8):897-902. PubMed ID: 32424420
[TBL] [Abstract][Full Text] [Related]
40. Basic science and clinical management of painful and non-painful chemotherapy-related neuropathy.
Kim JH; Dougherty PM; Abdi S
Gynecol Oncol; 2015 Mar; 136(3):453-9. PubMed ID: 25584767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
